Oliver's mTOR Atlas Evidence Platform
Reading level
Mode

Pathway link TRANSL-MUSCLE

Protein synthesis Muscle growth

Protein synthesis activates Muscle growth.

Ongoing protein-building is what physically builds muscle; in mice, the signals that drive it are needed for muscle growth and are enough to cause it. In people, blocking mTOR blunts the rise in muscle protein-building after a single bout of exercise, but how much muscle is gained over months under the drug was not measured.

Sustained protein synthesis is what physically builds muscle; in mice, Akt/mTOR signalling is necessary and sufficient for hypertrophy (BOD2001). In people, blocking mTOR blunts the short-term rise in muscle protein synthesis after exercise (DRU2009); whether that changes how much muscle is gained over months was not measured.

The conditions it holds under

Mouse (BOD2001) and cultured myotubes (ROM2001). The human study DRU2009 is cited on the step before this one (LOAD-MTORC1): rapamycin blocked the rise in muscle protein synthesis 1-2 h after one bout of contractions (and also blocked ERK1/2). It did not measure muscle growth, so it is not evidence for this arrow.

Requires mechanical load. mTORC1 activation without loading does not reproduce healthy hypertrophy, and constitutive activation alone is not sufficient.

Time it takes
days
Step
indirect (through steps not drawn here)
Measured in
mouse, mouse myotubes
Reaches people?
plausible in people, not shown directly
How settled
settled in the literature

Studies behind it

YearEvidenceStudy
2001 A Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivoBOD2001 Akt/mTOR signalling is necessary and sufficient to drive skeletal-muscle hypertrophy and counteract atrophy in vivo.
2001 M Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathwaysROM2001 Shows IGF-1 drives muscle fiber hypertrophy through Akt, via both the mTOR and GSK3 branches, in cultured myotubes, establishing mTOR as a central node for muscle growth signaling.

Points the other way

YearEvidenceStudy
2026 A Feeding-Induced Muscle mTORC1 Signaling Regulates Postprandial Protein Synthesis and Endurance but Not Muscle SizeLAP2026 Using a mouse model expressing an AKT-nonphosphorylatable TSC2 mutant specifically in skeletal muscle, the Manning lab genetically separated feeding-induced from contraction-induced mTORC1 activation. AKT-mediated TSC2 phosphorylation is required for feeding (but not contraction) to activate muscle mTORC1 and drive postprandial protein synthesis — yet mice lacking this feeding-induced signal have normal muscle mass and myofiber size, and instead show improved maximal endurance capacity with a modest rise in mitochondrial content. The finding dissociates mTORC1's role in postprandial anabolism from its role in maintaining steady-state muscle mass, and is a directly relevant data point for whether the pattern/source of mTORC1 activation (feeding vs. mechanical) — not just its average level — shapes downstream outcomes.

Who has checked this

Checked by
No researcher outside the project has checked this link yet.
Curator sign-off
Not signed off yet. This link was drafted with AI help and has not been reviewed link by link; treat it as a proposal until it is.
Curated by
Oliver Barton, with AI help for drafting; see how links are checked.

“How settled” describes how far researchers in the field agree. It is not the same as the sign-off above, which only says whether a named curator has checked this page.

If this link rests on your own work: a click on “This looks right” below, or a short note through “Report an error”, helps us more than anything else on this page.

← The whole pathway · This link as JSON

Was this page useful?
Spotted something wrong or out of date about this link?